Search - tctmd.com

Displaying 401 - 420 of 637

Sort: Relevancy | Date

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

Presentation TCT 2014

Physiology Studies Evaluating Clinical Outcomes Using iFR: FLAIR, SweedeHeart, Syntax II, and Prospect II

Presenter: Bernard De Bruyne, Manesh R. Patel, Allen Jeremias, Javier Escaned

September 14, 2014

Presentation TCT 2014

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

Presenter: Steven R. Bailey, Surya Dharma

September 14, 2014

Presentation TCT 2014

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

Presenter: Steven R. Bailey, Gennaro Sardella

September 14, 2014

Presentation TCT 2014

RADIATION PROTECT: A Prospective, Randomized Trial of a Novel Pelvic Lead Shield and a Novel, Non-Lead Surgical Cap to Reduce Operator Radiation Exposure During Coronary Angiography

Presenter: Steven R. Bailey, Ashraf Alazzoni

September 14, 2014

Presentation TCT 2014

OCT STEMI: A Prospective, Randomized Trial of Optical Coherence Tomography Guidance During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Gary S. Mintz, Ioannis Iakovou, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

IVUS-CTO: A Prospective, Randomized Trial of Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Intervention in Coronary Chronic Total Occlusions

Presenter: Gary S. Mintz, Ioannis Iakovou, Yang-Soo Jang

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

DKCRUSH-VI: A Prospective, Randomized Trial of FFR-Guided Versus Angiography-Guided Provisional T-Stenting in Patients with True Coronary Bifurcation Lesions

Presenter: Gregg W. Stone, Pieter C. Smits, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Daily News

La Angina Supera a la Isquemia como Predictor de los Resultados de la EAC Estable

Todd Neale

August 20, 2014

News Daily News

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

Todd Neale

August 20, 2014

News Industry News

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

August 15, 2014

Advertisement

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

Physiology Studies Evaluating Clinical Outcomes Using iFR: FLAIR, SweedeHeart, Syntax II, and Prospect II

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

RADIATION PROTECT: A Prospective, Randomized Trial of a Novel Pelvic Lead Shield and a Novel, Non-Lead Surgical Cap to Reduce Operator Radiation Exposure During Coronary Angiography

OCT STEMI: A Prospective, Randomized Trial of Optical Coherence Tomography Guidance During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

IVUS-CTO: A Prospective, Randomized Trial of Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Intervention in Coronary Chronic Total Occlusions

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

DKCRUSH-VI: A Prospective, Randomized Trial of FFR-Guided Versus Angiography-Guided Provisional T-Stenting in Patients with True Coronary Bifurcation Lesions

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

COMPARE II: BES, EES Show Similar Outcomes at Three Years

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

European Societies Release Updated Revascularization Guidelines for CAD

Elixir Medical Announces Schedule of Programs for TCT 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

La Angina Supera a la Isquemia como Predictor de los Resultados de la EAC Estable

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content